ODD vs ELF vs SKIN

For growth investors, e.

l. f. Beauty, Inc. (ELF) is the stronger pick with 28. 3% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Oddity Tech Ltd. (ODD) offers the better valuation at 8. 3x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate e. l. f. Beauty, Inc. (ELF) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Oddity Tech Ltd.

(ODD) is the cheapest at 8. 3x versus e. l. f. Beauty, Inc. at 32. 2x. On forward P/E, e. l. f. Beauty, Inc. is actually cheaper at 19. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Oddity Tech Ltd. wins at 0. 21x versus e. l. f. Beauty, Inc. 's 0. 49x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, e.

l. f. Beauty, Inc. (ELF) delivered a total return of +105. 0%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: ELF returned +133. 1% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Oddity Tech Ltd.

(ODD) is the lower-risk stock at 0. 71β versus e. l. f. Beauty, Inc. 's 2. 36β — meaning ELF is approximately 231% more volatile than ODD relative to the S&P 500. On balance sheet safety, Oddity Tech Ltd. (ODD) carries a lower debt/equity ratio of 10% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), e.

l. f. Beauty, Inc. (ELF) is pulling ahead at 28. 3% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -13. 1% for e. l. f. Beauty, Inc.. Over a 3-year CAGR, ELF leads at 49. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oddity Tech Ltd.

(ODD) is the more profitable company, earning 13. 7% net margin versus -3. 2% for The Beauty Health Company — meaning it keeps 13. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ODD leads at 14. 7% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — ODD leads at 72. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Oddity Tech Ltd. (ODD) is the more undervalued stock at a PEG of 0. 21x versus e. l. f. Beauty, Inc. 's 0. 49x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, e. l. f. Beauty, Inc. (ELF) trades at 19. 9x forward P/E versus 20. 2x for Oddity Tech Ltd. — 0. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ODD: 131. 7% to $34. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Oddity Tech Ltd.

(ODD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71)). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ODD: -68. 7%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ODD (Technology) and ELF (Consumer Defensive) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ODD is a small-cap high-growth stock; ELF is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.